연구성과로 돌아가기
JCR 2023 저널 목록 (1201 / 2065)
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Journal Name | Publisher | ISSN | eISSN | Edition | WoS Category | Total Citation | JIF | JIF Quartile | 상위 JCR(%) | JIF % | JIF Rank | 5-Year JIF | 5-Year Quartile | JIF w/o Self-Cites | Immediacy Index | JCI | JCI Rank | JCI Quartile | JCI Percentile | Eigenfactor Score | Normalized Eigenfactor | Article Influence Score | AIS Quartile | Citable Items | Articles in Citable Items (%) | Cited Half-Life | Citing Half-Life | Total Articles | Citable OA (%) | 수집시기 | 바로가기 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Occupational Therapy International | WILEY-HINDAWI | 0966-7903 | 1557-0703 | SCIE, SSCI | REHABILITATION | 999 | 1.3 | Q3 | 62.6 | 37.4 | 107/170 | 1.6 | Q3 | 1.0 | 0.3 | 0.67 | 102/170 | Q3 | 40.29 | 0.001 | 0.149 | 0.325 | Q4 | 38 | 84.2% | 7.3 | 7.9 | 32 | 100.0% | 2025-03-24 18:08:28 | 바로가기 |
| Open Veterinary Journal | UNIV TRIPOLI, FAC VET MED | 2226-4485 | 2218-6050 | ESCI | VETERINARY SCIENCES | 694 | 0.9 | Q3 | 62.6 | 37.4 | 105/167 | 1.1 | Q3 | 0.8 | 0.1 | 0.44 | 106/168 | Q3 | 37.20 | 0.001 | 0.165 | 0.214 | Q3 | 201 | 95.5% | 4.5 | 9.7 | 192 | 96.0% | 2025-03-24 18:15:28 | 바로가기 |
| PATHOLOGY & ONCOLOGY RESEARCH | FRONTIERS MEDIA SA | 1219-4956 | 1532-2807 | SCIE | ONCOLOGY | 3,711 | 2.3 | Q3 | 62.6 | 37.4 | 202/322 | 2.4 | Q3 | 2.3 | 0.5 | 0.70 | 146/322 | Q2 | 54.81 | 0.004 | 0.799 | 0.493 | Q4 | 94 | 79.8% | 4.8 | 5.9 | 75 | 99.2% | 2025-03-24 17:33:50 | 바로가기 |
| Pediatric Physical Therapy | LIPPINCOTT WILLIAMS & WILKINS | 0898-5669 | 1538-005X | SCIE | REHABILITATION | 1,534 | 1.3 | Q3 | 62.6 | 37.4 | 107/170 | 1.6 | Q3 | 1.2 | 0.4 | 0.63 | 109/170 | Q3 | 36.18 | 0.001 | 0.188 | 0.414 | Q3 | 42 | 81.0% | 9.7 | 9.2 | 34 | 1.4% | 2025-03-24 18:08:23 | 바로가기 |
| Pharmacoeconomics-Open | SPRINGER INT PUBL AG | 2509-4262 | 2509-4254 | ESCI | PHARMACOLOGY & PHARMACY | 678 | 2.0 | Q3 | 62.6 | 37.4 | 222/354 | 2.0 | Q3 | 1.9 | 0.3 | 0.59 | 203/354 | Q3 | 42.80 | 0.002 | 0.404 | 0.728 | Q2 | 76 | 84.2% | 3.4 | 6.7 | 64 | 98.0% | 2025-03-24 17:36:42 | 바로가기 |
| Pharmacy | MDPI | N/A | 2226-4787 | ESCI | PHARMACOLOGY & PHARMACY | 2,254 | 2.0 | Q3 | 62.6 | 37.4 | 222/354 | 2.2 | Q3 | 1.8 | 0.4 | 0.50 | 235/354 | Q3 | 33.76 | 0.004 | 0.773 | 0.492 | Q3 | 183 | 76.5% | 3.6 | 6.9 | 140 | 99.8% | 2025-03-24 17:36:33 | 바로가기 |
| Physical Communication | ELSEVIER | 1874-4907 | 1874-4907 | SCIE | TELECOMMUNICATIONS | 2,193 | 2.0 | Q3 | 62.6 | 37.4 | 75/119 | 1.7 | Q3 | 1.8 | 0.6 | 0.55 | 69/119 | Q3 | 42.44 | 0.003 | 0.584 | 0.323 | Q3 | 225 | 97.8% | 3.1 | 4.5 | 220 | 4.2% | 2025-03-24 18:13:33 | 바로가기 |
| PROCEEDINGS OF THE INSTITUTION OF MECHANICAL ENGINEERS PART D-JOURNAL OF AUTOMOBILE ENGINEERING | SAGE PUBLICATIONS LTD | 0954-4070 | 2041-2991 | SCIE | ENGINEERING, MECHANICAL | 4,409 | 1.5 | Q3 | 62.6 | 37.4 | 115/183 | 1.7 | Q3 | 1.2 | 0.2 | 0.34 | 131/183 | Q3 | 28.69 | 0.003 | 0.764 | 0.291 | Q3 | 300 | 91.3% | 4.8 | 6.1 | 274 | 2.8% | 2025-03-24 17:11:49 | 바로가기 |
| Prostate Cancer | HINDAWI LTD | 2090-3111 | 2090-312X | ESCI | ONCOLOGY | 281 | 2.3 | Q3 | 62.6 | 37.4 | 202/322 | 2.1 | Q3 | 2.3 | 4.0 | 0.24 | 282/322 | Q4 | 12.58 | 0.000 | 0.046 | 0.572 | Q3 | 2 | 100.0% | 8.7 | N/A | 2 | 100.0% | 2025-03-24 17:34:07 | 바로가기 |
| Seminars in Oncology Nursing | ELSEVIER SCIENCE INC | 0749-2081 | 1878-3449 | SCIE | ONCOLOGY | 2,278 | 2.3 | Q3 | 62.6 | 37.4 | 202/322 | 4.3 | Q2 | 2.2 | 0.4 | 0.69 | 151/322 | Q2 | 53.26 | 0.003 | 0.572 | 1.051 | Q2 | 105 | 88.6% | 5.2 | 6.4 | 93 | 20.2% | 2025-03-24 17:33:55 | 바로가기 |
| SOLVENT EXTRACTION AND ION EXCHANGE | TAYLOR & FRANCIS INC | 0736-6299 | 1532-2262 | SCIE | CHEMISTRY, MULTIDISCIPLINARY | 2,396 | 1.8 | Q3 | 62.6 | 37.4 | 145/231 | 2.7 | Q2 | 1.7 | 0.7 | 0.34 | 141/231 | Q3 | 39.18 | 0.001 | 0.143 | 0.433 | Q2 | 40 | 97.5% | 12.6 | 10.7 | 39 | 9.3% | 2025-03-24 16:59:35 | 바로가기 |
| SURGICAL ONCOLOGY-OXFORD | ELSEVIER SCI LTD | 0960-7404 | 1879-3320 | SCIE | ONCOLOGY | 3,303 | 2.3 | Q3 | 62.6 | 37.4 | 202/322 | 2.5 | Q3 | 2.2 | 0.3 | 0.71 | 143/322 | Q2 | 55.75 | 0.004 | 0.886 | 0.660 | Q3 | 77 | 88.3% | 5.5 | 7.2 | 68 | 10.9% | 2025-03-24 17:33:51 | 바로가기 |
| Therapeutic Innovation & Regulatory Science | SPRINGER HEIDELBERG | 2168-4790 | 2168-4804 | SCIE | PHARMACOLOGY & PHARMACY | 1,382 | 2.0 | Q3 | 62.6 | 37.4 | 222/354 | 1.6 | Q4 | 1.8 | 0.2 | 0.38 | 276/354 | Q4 | 22.18 | 0.003 | 0.631 | 0.557 | Q3 | 104 | 74.0% | 3.7 | 7.5 | 77 | 42.7% | 2025-03-24 17:36:38 | 바로가기 |
| Thoracic Cancer | WILEY | 1759-7706 | 1759-7714 | SCIE | ONCOLOGY | 5,804 | 2.3 | Q3 | 62.6 | 37.4 | 202/322 | 2.8 | Q3 | 2.2 | 0.3 | 0.61 | 175/322 | Q3 | 45.81 | 0.010 | 2.142 | 0.655 | Q3 | 374 | 94.6% | 3.5 | 5.5 | 354 | 68.4% | 2025-03-24 17:33:45 | 바로가기 |
| VISION RESEARCH | PERGAMON-ELSEVIER SCIENCE LTD | 0042-6989 | 1878-5646 | SCIE | OPHTHALMOLOGY | 13,300 | 1.5 | Q3 | 62.6 | 37.4 | 60/95 | 1.7 | Q3 | 1.4 | 0.6 | 0.60 | 59/95 | Q3 | 38.42 | 0.003 | 0.664 | 0.594 | Q3 | 88 | 98.9% | 18.5 | 12.9 | 87 | 28.2% | 2025-03-24 17:34:23 | 바로가기 |
페이지 이동: